Journal Home
Search for

Volume 20, Issue 3, Pages 261-267 (May 2009)


View previous. 8 of 31 View next.

Progressive multifocal leukoencephalopathy, a review and an extended report of five patients with different immune compromised states

Jelle L. EpkeraCorresponding Author Informationemail address, Paula van Biezenb, Paul L.A. van Daelec, Teun van Gelderd, Ann Vossene, Jan L.C.M. van Saasef

Received 4 February 2008; received in revised form 19 May 2008; accepted 7 July 2008. published online 01 September 2008.

Abstract 

Progressive multifocal leukoencephalopathy (PML) is an opportunistic infection of the brain caused by the JC-virus. Both a decreased cellular or humoral immune response can increase the susceptibility for JC-virus induced PML. Not only HIV infected people are at risk, a wide range of otherwise immune compromised patients are a potential target for this virus. This report of five PML patients shows the importance of a clinician's familiarity with this disease and it's presenting symptoms. The presenting symptoms of PML can sometimes mimic worsening of the underlying disease. Although different therapeutic strategies have been tried, the outcomes remain very poor. In this series, treatment with cidofovir appears not to be effective in treating PML, neither in HIV positive nor HIV negative patients. Experimental therapy with leflunomide, after tapering of the immunosuppressive medication, did change the natural course of PML in one patient.

a Erasmus Medical Centre, Department of Intensive Care Medicine, The Netherlands

b Erasmus Medical Centre, Department of Internal Medicine and Infectious Diseases, The Netherlands

c Erasmus Medical Centre, Department of Internal Medicine and Immunology, The Netherlands

d Erasmus Medical Centre, Departments of Internal Medicine and Hospital Pharmacy, The Netherlands

e Leiden University Medical Centre, Department of Medical Microbiology, The Netherlands

f Erasmus Medical Centre, Departments of Internal Medicine and Nephrology, The Netherlands

Corresponding Author InformationCorresponding author. Erasmus Medical Centre, Department of Intensive Care Medicine, 6 zuid, Postbus 2040, 3000 CA Rotterdam, The Netherlands. Tel.:+31 6 44460607; fax: +31 10 7042874.

PII: S0953-6205(08)00207-0

doi:10.1016/j.ejim.2008.07.032


View previous. 8 of 31 View next.